US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Latest News about CYB004

Recent news which mentions CYB004

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
Tickers CYBN NEWS
Tags General CYB004 Trading Ideas
From Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
Tickers CYBN DMT
Tags Market News first/in/human dosing Markets
From Benzinga